Krystal Biotech Inc.

KRYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$333.85

-$2.82 (-0.84%)

At close: Sep 21, 2026, 4:00 PM ET

$333.85

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $9.92B

Enterprise Value $9.01B

Beta 0.54

Average Volume 375.86K

Shares Outstanding (Diluted) 30.66M

Shares Change YoY 3.05%

Institutional Ownership 96.89%

Exchange NASDAQ

ISIN US5011471027

Price Performance

Price Change 1M -1.8%

Price Change 3M -1.9%

Price Change 6M 30.9%

Price Change YTD 35.2%

Price Change 1Y 101.8%

Price Change 3Y 189.9%

Price Change 5Y 493.1%

1M CAGR (ann.) 4.3%

1Y CAGR (ann.) 118.5%

5Y CAGR (ann.) 42.1%

All-Time CAGR 46.8%

Valuation

PE Ratio 41.84

Forward PE 32.51

PEG Ratio 0.65

Forward PEG 1.70

PS Ratio 22.34

Forward PS 14.80

PB Ratio 7.24

P/FCF Ratio 38.18

P/Adj. FCF Ratio 45.51

P/OCF Ratio 36.21

EV/Sales 20.44

EV/EBIT 42.21

EV/EBITDA 41.23

EV/FCF 34.93

Earnings Yield 2.4%

FCF Yield 2.6%

Adj. FCF Yield 2.2%

Financial Health

Net Cash $845.63M

Total Debt $8.85M

Cash & Short-Term Investments $845.63M

Total Assets $1.5B

Current Ratio 8.32

Quick Ratio 7.96

Debt / Equity Ratio 0.01

Debt / EBITDA 0.04

Debt / FCF 0.03

OCF / Debt 30.76

Interest Coverage 0.00

Altman Z-Score 43.71

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 93.3%

Operating Profit Margin 44.9%

EBITDA Margin 49.6%

Net Profit Margin 54.8%

FCF Margin 58.5%

Adj. FCF Margin 49.1%

SBC / Revenue 9.4%

SBC Impact (per share) -16.1%

Returns

Return on Assets 16.1%

Return on Equity 19.3%

Return on Invested Capital 14.4%

Return on Capital Employed 14.4%

Return on Tangible Assets 16.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 42.6%

Revenue CAGR 5Y 64.2%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 39.2%

EPS CAGR 5Y 282.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y 100.1%

FCF CAGR 5Y 551.5%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 17

EPS Growth Next 3Y 55.8%

Revenue Growth Next 3Y 56.0%

Earnings Date Nov 1, 2026

EPS Estimate (next Q) $1.91

EPS Growth Est (next Q) -28.2%

Revenue Est (next Q) $129.65M

Revenue Growth Est (next Q) 32.6%

Fair Value Estimates

Graham Number $90.91

Graham Upside -72.8%

Lynch Fair Value $199.50

Lynch Upside -40.2%

Price Target $383.75

Price Target Upside 14.9%

Cash Flow

Operating Cash Flow $272.34M

Free Cash Flow $257.78M

Adj. Free Cash Flow $216.25M

FCF Per Share $8.73

OCF Per Share $9.22

OCF/S Ratio 61.8%

Income Statement

Revenue $440.48M

Gross Profit $411.14M

Operating Income $197.92M

EBITDA $218.43M

Net Income $241.47M

EPS (Diluted) $7.98

Revenue / Employee $1.49M

Profit / Employee $818.53K

Employees 295